UK company record
Microbiotica
Microbiome-based Live Bacterial Therapeutics
VerifiedCore UK
Snapshot
- UK location
- Cambridge · East of England
- Sector
- Biotech & techbio
- Latest recorded round
- Series B
- Latest recorded amount
- £50M
- Date
- 2022-03-07
Legal-identity layer
Verified identity.
- Selected legal name
- MICROBIOTICA LIMITED
- Company number
- 10269808
- Companies House status
- active
- Incorporated
- 2016-07-08
Investors
- IP GroupLead
- Cambridge Innovation CapitalLead
- Flerie InvestLead
- TencentLead
- British Patient CapitalParticipant
- Cambridge Innovation CapitalParticipant
- IP GroupParticipant
- Seventure PartnersParticipant
Current directors and active controllers
- CIRCELLI, Carmine Daniel, Dr.Current director
- HORGAN, Viet-Anh Anne, DrCurrent director
- IP2IPO SERVICES LIMITEDCurrent director
- LAWLEY, Trevor David, DrCurrent director
- QUICK, Mark RoystonCurrent director
- SCHIKAN, Johannes Gerardus Christiaan PetrusCurrent director
- SHARPINGTON, TimothyCurrent director
- Cambridge Innovation Capital LimitedFormer controller
- DOUGAN, Gordon, Professordirector
- Dr Trevor David LawleyFormer controller
- GARDNER, Rowena Tracysecretary
- Ip2ipo Portfolio (Gp) LimitedFormer controller
- LYNCH, Thomas Gerarddirector
- Mr Michael Anthony RomanosFormer controller
- ROMANOS, Michael Anthonydirector
- SHIELDS, John Gerard, Drdirector
- TANSLEY, Robert Giles, Drdirector
- WILCOCK, Iain Charles Stephendirector
Funding rows
- Seed£8M · 2016-12-15
- Series B£50M · 2022-03-07
Sources
- https://microbiotica.com/cambridge-innovation-capital-plc-and-ip-group-plc-announce-the-creation-of-wellcome-trust-sanger-institute-spin-out-company-microbiotica/
- https://www.businesswire.com/news/home/20220307005475/en/Microbiotica-Raises-%C2%A350m-%2467m-to-Advance-Pipeline-of-Microbiome-based-Therapeutics